Table 4 |
||||
|
Association between immunostaining and Fuhrman grade and stage. |
||||
|
Immunostaining |
||||
|
Fuhrman grade or stage |
Marker |
immunonegative, n (%) |
immunopositive, n (%) |
p-value |
|
|
||||
|
grade I |
serotonin |
5 (100) |
0 (0) |
0.2 |
|
grade II |
75 (95) |
4 (5) |
||
|
grade III |
31 (84) |
6 (16) |
||
|
grade IV |
20 (91) |
2 (9) |
||
|
stage I |
serotonin |
60 (91) |
6 (9) |
0.6 |
|
stage II |
9 (90) |
1 (10) |
||
|
stage III |
45 (90) |
5 (10) |
||
|
stage IV |
19 (100) |
0 (0) |
||
|
grade I |
CD56 |
5 (100) |
0 (0) |
0.7 |
|
grade II |
65 (83) |
13 (17) |
||
|
grade III |
29 (78) |
8 (22) |
||
|
grade IV |
17 (77) |
5 (23) |
||
|
stage I |
CD56 |
59 (88) |
8 (12) |
0.2 |
|
stage II |
7 (70) |
3 (30) |
||
|
stage III |
38 (78) |
11 (22) |
||
|
stage IV |
14 (78) |
4 (22) |
||
|
grade I |
NSE |
0 (0) |
5 (100) |
0.1 |
|
grade II |
41 (52) |
38 (48) |
||
|
grade III |
22 (56) |
17 (44) |
||
|
grade IV |
11 (55) |
9 (45) |
||
|
stage I |
NSE |
35 (52) |
32 (48) |
0.6 |
|
stage II |
6 (55) |
5 (45) |
||
|
stage III |
28 (57) |
21 (43) |
||
|
stage IV |
7 (39) |
11 (61) |
||
|
|
||||
|
Ronkainen et al. Diagnostic Pathology 2010 5:28 doi:10.1186/1746-1596-5-28 |
||||
